Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Janssen receives patent for new antihistaminic series

Aug. 11, 2000

Pulmicort Respules approved in U.S. for children aged 1 to 8 years

Aug. 9, 2000

MSI-ipratropium trial reveals efficacy of new delivery system

Aug. 9, 2000

New alpha4-integrin antagonists useful for asthma, etc.

Aug. 8, 2000

New compounds interacting with chemokine receptors under study at DuPont

Aug. 7, 2000

Texas Biotechnology announces initial financing of Revotar subsidiary

Aug. 4, 2000

New compounds under development at AHP for treatment of inflammatory and autoimmune diseases

Aug. 3, 2000

Amiloride fails to show benefit in cystic fibrosis trial

Aug. 3, 2000

Researchers determine the structure of antibody-receptor complex key to allergies and asthma

Aug. 2, 2000

Recently issued patent covers B-I's new heterocyclic PDE4 inhibitors

Aug. 1, 2000

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...